-
Ferring Announces Recipients of Innovation Grants Program 2017-2018
-Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute…
0 -
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
-Ferring Pharmaceuticals announced today that it has entered into a worldwide license agreement with Ligand Pharmaceuticals to use…
-
Global agreement with FKD to commercialise novel gene therapy for bladder cancer patients
-Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Acquisition of Rebiotix Inc. Microbiota Restoration Therapy
-Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Ferring and the Chinese Academy of Sciences collaborate to advance research in reproductive medicine
-Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic…
-
Launch of Testavan® (testosterone)
-Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Archive for January, 2018
2018 > January